Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Topical minoxidil can promote hair growth in men with hereditary hair loss, with no serious side effects.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Hospital staff have a higher rate of hair loss than the general population.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Different hair loss patterns may be linked to varying male hormone levels.

Male pattern baldness affects 38.52% of Asian men in Bangkok, increasing with age and influenced by genes and environment.

Finasteride works better than Serenoa repens for male hair loss.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Sophora flavescens extract may help hair grow by affecting growth factors and blocking a hair-related enzyme.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Genes and hormones cause hair loss, with four genes contributing equally.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Finasteride effectively treats hair loss in Korean men for at least 5 years, with V type responding better.

The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.

Cyclosporin doesn't stop hair loss.